Biomarker Discovery Firm Biospect Raises $27M in Financing, Appoints CEO | GenomeWeb

Biomarker Discovery Firm Biospect Raises $27M in Financing, Appoints CEO

Oct 21, 2003

NEW YORK, Oct. 21 (GenomeWeb News) - Biospect, a South San Francisco, Calif.-based startup developing systems for detecting biomarker patterns, today said it has received more than $27 million in equity financing from four venture capital firms: Advent Venture Partners, Prospect Venture Partners, Venrock Associates, and Versant Ventures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Prize for Five

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Sure, Blame the Test

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

This Week in Genome Research

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Low Down Syndrome Rates in Iceland

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.